Featured Story | By Amirah Al Idrus With final phase 3 data in hand, Vir Biotechnology and GlaxoSmithKline are seeking full approval for their COVID-19 antibody by the end of the year. The study found that the treatment, sotrovimab, slashed hospitalizations and deaths by 79% in adults with mild to moderate COVID-19 who were at high risk of their disease becoming severe. read more |
| |
|---|
|
|  | Webinar: Five Common Mistakes in Panel Management Wednesday, July 14, 2021 | 1pm ET / 10am PT It takes time and focus to keep your panel in good health. By learning common pitfalls, this webinar will assist you in refining your panel management strategy and best practices to keep your respondents motivated and engaged. Register now. |
Top Stories By Ben Adams WuXi veteran Shuyuan Yao, Ph.D., is stepping down from the Chinese R&D giant to lead the new joint venture, Allogene Overland Biopharm. read more By Kyle LaHucik Arrowhead Pharmaceuticals will bring an RNA interference therapeutic through preclinical stages and Horizon will handle clinical development and commercialization for the potential gout treatment. read more Sponsored by: Oracle Health Sciences In a recent virtual roundtable discussion, industry experts shared their insight on the challenges faced in implementing decentralized trials and how to address them. read more By Ben Adams Australian biotech Immutep has secured $60 million Australian dollars through a “two-tranche institutional placement” as it eyes a deeper push into the clinic and looks to raise a further AU$5 million via a share purchase plan. read more Sponsored by Alexion By refocusing company culture around the connection between employees and the rare disease community, Alexion has increased employee engagement and charted a new path for business success. Read more. read more By Kyle LaHucik Tarsus Pharmaceuticals met all primary and secondary endpoints in a pivotal phase 2b/3 trial of its eyedrop treatment for eyelid mange, and expects to file for regulatory approval next year following results of another pivotal study already underway. read more By Arlene Weintraub Experimental anti-amyloid antibodies from Eli Lilly and Roche failed to improve symptoms of Alzheimer’s disease in a phase 2/3 study, but analysis of the the trial continued. Now, the investigators at Washington University are extending the trial of Roche’s drug based on findings suggesting it may help a subset of patients. read more By Beth Snyder Bulik Environmental, Social and Governance (ESG) is the new corporate sustainability yardstick. And investors are pushing ESG accountability—thanks in part to the pandemic—to the front page across industries, including pharma. read more Resources Sponsored by: Clinical Ink For faster deployment, improved patient engagement, and better-quality data — go where your patients are. GO BYOD with Lunexis™ from Clinical Ink. Sponsored by SDG Group Discover how Ashfield Healthcare uses the power of data and analytics to enable pre-call planning, inform sales rep actions and drive higher market share for its target pharmaceutical products. Sponsored by: BBK Worldwide Create a more diverse and inclusive clinical trial enrollment and engagement environment by learning the barriers to participation and the strategies to overcome them. Sponsored by: Thermo Fisher Scientific Autologous cell and gene therapy workflows involve isolating cells from an individual, engineering the cells, expanding and concentrating them, and infusing them back into the patient. Optimized automation of certain steps of the workflow may decrease hands-on time and the cost of the cell manufacturing process. Sponsored By: Veeva Learn how to develop a standards program that has your full team’s buy-in and improves the efficiency and quality of your clinical trials. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. | 
